Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
13.32
-0.13 (-0.97%)
Apr 29, 2026, 3:04 PM CST
SHE:002675 Revenue
Yantai Dongcheng Pharmaceutical Group had revenue of 626.37M CNY in the quarter ending March 31, 2026, a decrease of -8.82%. This brings the company's revenue in the last twelve months to 2.68B, down -7.84% year-over-year. In the year 2025, Yantai Dongcheng Pharmaceutical Group had annual revenue of 2.74B, down -4.46%.
Revenue (ttm)
2.68B
Revenue Growth
-7.84%
P/S Ratio
4.10
Revenue / Employee
1.04M
Employees
2,583
Market Cap
10.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.74B | -127.86M | -4.46% |
| Dec 31, 2024 | 2.87B | -406.71M | -12.42% |
| Dec 31, 2023 | 3.28B | -307.31M | -8.58% |
| Jan 1, 2023 | 3.58B | -329.09M | -8.41% |
| Jan 1, 2022 | 3.91B | 493.07M | 14.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Mayinglong Pharmaceutical Group | 3.91B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Porton Pharma Solutions | 3.50B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 4.94B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Guangdong Taienkang Pharmaceutical | 674.49M |